Animal Growth Promoters and Performance Enhancers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Non-antibiotic Growth Promoters, Antibiotic Growth Promoters), By Animal Type (Poultry, Livestock, Swine, Aquatic Animals, Other Animals), By Region, and Competition

Published Date: February - 2025 | Publisher: MIR | No of Pages: 320 | Industry: Agriculture | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Animal Growth Promoters and Performance Enhancers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Non-antibiotic Growth Promoters, Antibiotic Growth Promoters), By Animal Type (Poultry, Livestock, Swine, Aquatic Animals, Other Animals), By Region, and Competition

Animal Growth Promoters and Performance Enhancers Market is anticipated to witness impressive growth during the forecast period. Market size was valued at USD 13.99 billion in 2023 and is poised to grow from USD 14.79 billion in 2024 to USD 23.04 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

 Download Sample  Ask for Discount  Request Customization 

In November 2018, BIOMIN Holding GmbH launched DIGESTAROM DC, a phytogenic feed additive, which claims to enhance the growth and performance of livestock animals.

Increasing Demand for Animal-based Products

Animal-based products play a crucial role in driving the global animal growth promoters and performance enhancers market. Animal growth promoters and performance enhancers are primarily used to improve the growth, health, and productivity of livestock, which ultimately leads to increased production of animal-based products.

Meat, milk, and eggs are the most common animal-based products that are produced using these enhancers. These products are in high demand globally due to increasing population, growing disposable incomes, and changing dietary habits.

Animal growth promoters and performance enhancers are also used to improve animal growth rates, increase feed efficiency, and enhance overall animal health. For example, antibiotics are commonly used to promote growth and prevent diseases in livestock. Hormones, beta-agonists, and enzymes are also used to enhance animal growth and performance. All these products ultimately result in higher productivity and profitability for producers, benefiting animal-based product businesses.

In addition to improving animal productivity, animal growth promoters and performance enhancers also have a positive impact on animal welfare. By reducing stress and disease, these products can help improve the health and well-being of livestock, which ultimately leads to high-quality animal-based products.

Download Free Sample Report Need to improve efficiency and productivity in the agriculture industry.

Efficiency and productivity are the key drivers in the global animal growth promoters and performance enhancers market. The use of these enhancers can help farmers and producers improve the efficiency and productivity of their operations, leading to higher profits and increased competition in the market.

These

The need to improve efficiency and productivity in the agriculture industry is driven by several factors, including the growing demand for animal-based products, increasing competition, and rising input costs. Animal growth promoters and performance enhancers can help address these challenges by improving animal health, reducing the incidence of disease, and increasing the efficiency of feed utilization.

Furthermore, the uptake of new technologies and the rise in R&D efforts are leading to the development of new and innovative products, which further contribute to the growth of the market. For example, probiotics and prebiotics are becoming increasingly popular as an alternative to antibiotics, which are increasingly facing scrutiny due to the potential for antibiotic resistance.

Technological Advancements and Increasing R&D Efforts

Technological advancements have a significant impact on the global animal growth promoters and performance enhancers market. The development of new and innovative products and technologies is enabling producers to improve animal health, increase productivity, and enhance the quality of animal-based products.

Furthermore, advancements in precision agriculture and data analytics have enabled producers optimize their operations and improve productivity. For example, sensors and monitoring systems can be used to track animal health and behavior, enabling producers to identify potential health issues and take corrective measures before they become serious.

The development of new feed additives, such as enzymes and probiotics, can improve the efficiency of feed utilization and enhance animal health, leading to increased productivity and profitability.


MIR Segment1

 Download Sample  Ask for Discount  Request Customization 

Increasing Awareness about Animal Welfare

The awareness regarding animal welfare influences the growth of the global animal growth promoters and performance enhancers market significantly. Consumers are increasingly concerned about the welfare of animals raised for food and are demanding that producers adopt more humane practices. This has led to a shift toward the use of natural and organic growth promoters and performance enhancers, which are perceived as being more sustainable and ethical.

Antibiotic resistance is a growing concern, and the use of antibiotics in animal production has been linked to the development of resistant bacteria that can be transmitted to humans. Hormones have also been linked to negative impacts on animal welfare, such as increased aggression and decreased reproductive performance.

Furthermore, some consumers are willing to pay a premium price for products that are certified as being produced using humane practices. This is creating a market for animal-based products that are produced using such methods, and subsequently, driving the uptake of more sustainable and ethical animal production practices, including the use of natural and organic growth promoters and performance enhancers.

Expanding Livestock Population

The livestock population is a significant factor that influences the growth of the global animal growth promoters and performance enhancers market. The size and composition of the livestock population directly impact the demand for animal growth promoters and performance enhancers, as these products are primarily used in the production of animal-based products, such as meat, milk, and eggs.

The global livestock population has been steadily increasing over the years due to the rising demand for animal-based products, driven by population growth and increasing incomes in developing countries. This increase in the livestock population is expected to drive the demand for animal growth promoters and performance enhancers in the near future. These products are used to improve the productivity of animals, increase their growth rates, and enhance the quality of animal-based products. For example, the use of growth-promoting antibiotics can increase the feed efficiency of animals, resulting in faster weight gain and improved meat quality.

Moreover, the increase in the livestock population is also leading to a high demand for animal health products, including vaccines, antibiotics, and other pharmaceuticals. The use of animal health products is essential to maintain the health and welfare of animals and improve their productivity, which in turn drives the demand for animal growth promoters and performance enhancers.

Recent Developments

  • Cibenza® DP100This product, launched by Novus International in 2021, is a combination of enzymes designed to improve the digestibility of poultry feed. The company claims that this product improves feed efficiency and reduces feed costs.
  • NutriScience Innovations' CLOSTAT®This product, launched in 2019, is a probiotic feed additive for poultry and swine. The company claims that it improves gut health, reduces the risk of disease, and enhances performance.
  • Elanco's Imrestor™This product, launched in 2018, is a monoclonal antibody that targets a protein that suppresses the cow's immune system during the transition period. The producer claims that it is a novel approach to improving dairy cow health and productivity, which helps in increasing milk production and reducing incidence of mastitis.
  • Biomin's Digestarom® DCThis product, launched in 2019, is a phytogenic feed additive, designed to improve the performance and health of swine and poultry. It contains a blend of essential oils and other natural compounds. The producer claims that it improves gut health and enhances digestion.
  • ADM Animal Nutrition's Axcelera-C®This product, launched in 2019, is a feed additive for beef cattle, designed to improve feed efficiency and weight gain. It contains a blend of organic acids and other compounds. The producer claims that it improves rumen health and nutrient utilization.
     

Market Segmentation

The global animal growth promoters and performance enhancers market can be segmented by type, animal type, and region. Based on the type, the market can be divided into non-antibiotic growth promoters and antibiotic growth promoters. Based on animal type, the market can be segmented into poultry, livestock, swine, aquatic animals, and other animals. Regionally, the market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.


MIR Regional

 Download Sample  Ask for Discount  Request Customization 

Market Players

  • Cargill Incorporated (US)

  • Royal DSM N.V. (Netherlands)

  • Boehringer Ingelheim Group (Germany)

  • Merck & Co. Inc (US)

  • Alltech Corporation (US)

  • Vetoquinol S.A. (France)

  • Novus International Inc (US)

  • Associated British Foods plc (UK)

  • Erber AG (Austria)

  • Phibro Animal Health Corporation (US)

  • Kemin Industries Inc (US)

  • Zoetis Inc (US)

  • Nutreco N.V. (Netherlands)

  • Novozymes A/S (Denmark)

  • BASF SE (Germany)

  • Evonik Industries AG (Germany)

  • Land O’Lakes Inc (US)

  • Lallemand Inc (Canada)

  • Attribute

    Details

    Base Year

    2022

    Historic Data

    2018 – 2021

    Estimated Year

    2023

    Forecast Period

    2024 – 2028

    Quantitative Units

    Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

    Report Coverage

    Revenue forecast, company share, competitive landscape, growth factors, and trends

    Segments Covered

    By Type

    By Animal Type

    By Region

    Regional scope

    North America; Europe; Asia Pacific; South America; Middle East & Africa

    Country scope

    United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

    Key companies profiled

    Cargill Incorporated., Royal DSM N.V., Elanco Animal Health Incorporated., Boehringer Ingelhem Group., Merck & Co. Inc., Archer Daniels Midland Company., Bluestar adisseo company., Alltech Corporation., Evonik Industries AG., Vetoquinol S A.

    Customization scope

    10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

    Pricing and purchase options

    Avail customized purchase options to meet your exact research needs. Explore purchase options

    Delivery Format

    PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Table of Content

Table of Contents

1 Executive Summary

2 Scope of the Report

2.1 Market Definition

2.2 Scope of the Study

2.2.1 Research Objectives

2.2.2 Assumptions & Limitations

2.3 Market Structure

3 Market Research Methodology

3.1 Research Process

3.2 Secondary Research

3.3 Primary Research

3.4 Forecast Model

4 Market Landscape

4.1 Supply Chain Analysis

4.1.1 Raw Material Suppliers

4.1.2 Manufacturers/Producers

4.1.3 Distributors/Retailers/Wholesalers/E-Commerce

4.1.4 End Users

4.2 Porter’s Five Forces Analysis

4.2.1 Threat of New Entrants

4.2.2 Bargaining Power of Buyers

4.2.3 Bargaining Power of Suppliers

4.2.4 Threat of Substitutes

4.2.5 Rivalry

5 Market Dynamics of the Global Animal Growth Promoters Enhancers Market

5.1 Introduction

5.2 Drivers

5.3 Restraints

5.4 Opportunities

5.5 Challenges

6. Global Animal Growth Promoters Enhancers Market, by Product Type

6.1 Introduction

6.2 Antibiotic

6.2.1 Market Estimates & Forecast, 2024–2032

6.2.2 Market Estimates & Forecast, by Region, 2024–2032

6.3 Hormonal

6.3.1 Market Estimates & Forecast, 2024–2032

6.3.2 Market Estimates & Forecast, by Region, 2024–2032

6.4 Feed Enzymes

6.4.1 Market Estimates & Forecast, 2024–2032

6.4.2 Market Estimates & Forecast, by Region, 2024–2032

6.5 Probiotics & Prebiotics

6.5.1 Market Estimates & Forecast, 2024–2032

6.5.2 Market Estimates & Forecast, by Region, 2024–2032

6.6 Phytogenic

6.6.1 Market Estimates & Forecast, 2024–2032

6.6.2 Market Estimates & Forecast, by Region, 2024–2032

6.7 Others

6.7.1 Market Estimates & Forecast, 2024–2032

6.7.2 Market Estimates & Forecast, by Region, 2024–2032

7. Global Animal Growth Promoters Enhancers Market, by Livestock

7.1 Introduction

7.2 Ruminants

7.2.1 Market Estimates & Forecast, 2024–2032

7.2.2 Market Estimates & Forecast, by Region, 2024–2032

7.3 Poultry

7.3.1 Market Estimates & Forecast, 2024–2032

7.3.2 Market Estimates & Forecast, by Region, 2024–2032

7.4 Porcine

7.4.1 Market Estimates & Forecast, 2024–2032

7.4.2 Market Estimates & Forecast, by Region, 2024–2032

7.5 Others

7.5.1 Market Estimates & Forecast, 2024–2032

7.5.2 Market Estimates & Forecast, by Region, 2024–2032

8. Global Animal Growth Promoters Enhancers Market, by Region

8.1 Introduction

8.2 North America

8.2.1 Market Estimates & Forecast, 2024–2032

8.2.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.2.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.2.4 US

8.2.4.1 Market Estimates & Forecast, 2024–2032

8.2.4.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.2.4.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.2.5 Canada

8.2.5.1 Market Estimates & Forecast, 2024–2032

8.2.5.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.2.5.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.2.6 Mexico

8.2.6.1 Market Estimates & Forecast, 2024–2032

8.2.6.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.2.6.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3 Europe

8.3.1 Market Estimates & Forecast, 2024–2032

8.3.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.4 Germany

8.3.4.1 Market Estimates & Forecast, 2024–2032

8.3.4.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.2.4.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.5 France

8.3.5.1 Market Estimates & Forecast, 2024–2032

8.3.5.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.5.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.6 Italy

8.3.6.1 Market Estimates & Forecast, 2024–2032

8.3.6.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.6.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.7 Spain

8.3.7.1 Market Estimates & Forecast, 2024–2032

8.3.7.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.7.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.8 UK

8.3.8.1 Market Estimates & Forecast, 2024–2032

8.3.8.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.8.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.3.9 Rest of Europe

8.3.9.1 Market Estimates & Forecast, 2024–2032

8.3.9.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.3.9.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4 Asia-Pacific

8.4.1 Market Estimates & Forecast, 2024–2032

8.4.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4.4 China

8.4.4.1 Market Estimates & Forecast, 2024–2032

8.4.4.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.4.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4.5 India

8.4.5.1 Market Estimates & Forecast, 2024–2032

8.4.5.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.5.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4.6 Japan

8.4.6.1 Market Estimates & Forecast, 2024–2032

8.4.6.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.6.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4.7 Australia & New Zealand

8.4.7.1 Market Estimates & Forecast, 2024–2032

8.4.7.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.7.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.4.8 Rest of Asia-Pacific

8.4.8.1 Market Estimates & Forecast, 2024–2032

8.4.8.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.4.8.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.5 Rest of the World (RoW)

8.5.1 Market Estimates & Forecast, 2024–2032

8.5.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.5.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.5.4 South America

8.5.4.1 Market Estimates & Forecast, 2024–2032

8.5.4.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.5.4.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.5.5 Middle East

8.5.5.1 Market Estimates & Forecast, 2024–2032

8.5.5.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.5.5.3 Market Estimates & Forecast, by Livestock, 2024–2032

8.5.6 Africa

8.5.6.1 Market Estimates & Forecast, 2024–2032

8.5.6.2 Market Estimates & Forecast, by Product Type, 2024–2032

8.5.6.3 Market Estimates & Forecast, by Livestock, 2024–2032

9. Company Landscape

9.1 Introduction

9.2 Market Strategies

9.3 Key Development Analysis

(Expansions/ Mergers and Acquisitions/ Joint Ventures/ New Product Developments/ Agreements/ Investments

10. Company Profiles

10.1 Bayer Animal Health GmbH

10.1.1 Company Overview

10.1.2 Financial Updates

10.1.3 Product/Business Segment Overview

10.1.4 Key Strategies

10.1.5 Key Developments

10.1.6 SWOT Analysis

10.2 Vétoquinol and Bioniche Life Sciences Inc.

10.2.1 Company Overview

10.2.2 Financial Updates

10.2.3 Product/Business Segment Overview

10.2.4 Key Strategies

10.2.5 Key Developments

10.2.6 SWOT Analysis

10.3 DSM N.V.

10.3.1 Company Overview

10.3.2 Financial Updates

10.3.3 Product/Business Segment Overview

10.3.4 Key Strategies

10.3.5 Key Developments

10.3.6 SWOT Analysis

10.4 Merck & Co., Inc.,

10.4.1 Company Overview

10.4.2 Financial Updates

10.4.3 Product/Business Segment Overview

10.4.4 Key Strategies

10.4.5 Key Developments

10.4.6 SWOT Analysis

10.5 Biomin Holding Gmbh

10.5.1 Company Overview

10.5.2 Financial Updates

10.5.3 Product/Business Segment Overview

10.5.4 Key Strategies

10.5.5 Key Developments

10.5.6 SWOT Analysis

10.6 Boehringer Ingelheim International GmbH

10.6.1 Company Overview

10.6.2 Financial Updates

10.6.3 Product/Business Segment Overview

10.6.4 Key Strategies

10.6.5 Key Developments

10.6.6 SWOT Analysis

10.7 Cargill Inc.

10.7.1 Company Overview

10.7.2 Financial Updates

10.7.3 Product/Business Segment Overview

10.7.4 Key Strategies

10.7.5 Key Developments

10.7.6 SWOT Analysis

10.8 Zoetis Inc.

10.8.1 Company Overview

10.8.2 Financial Updates

10.8.3 Product/Business Segment Overview

10.8.4 Key Strategies

10.8.5 Key Developments

10.8.6 SWOT Analysis

10.9 AB Vista Inc.

10.9.1 Company Overview

10.9.2 Financial Updates

10.9.3 Product/Business Segment Overview

10.9.4 Key Strategies

10.9.5 Key Developments

10.9.6 SWOT Analysis

10.10 The Alltech Group

10.10.1 Company Overview

10.10.2 Financial Updates

10.10.3 Product/Business Segment Overview

10.10.4 Key Strategies

10.10.5 Key Developments

10.10.6 SWOT Analysis

10.11 Elanco Animal Health Incorporated

10.11.1 Company Overview

10.11.2 Financial Updates

10.11.3 Product/Business Segment Overview

10.11.4 Key Strategies

10.11.5 Key Developments

10.11.6 SWOT Analysis

10.12 Bupo Animal Health

10.12.1 Company Overview

10.12.2 Financial Updates

10.12.3 Product/Business Segment Overview

10.12.4 Key Strategies

10.12.5 Key Developments

10.12.6 SWOT Analysis

10.13 Chr. Hansen A/S

10.13.1 Company Overview

10.13.2 Financial Updates

10.13.3 Product/Business Segment Overview

10.13.4 Key Strategies

10.13.5 Key Developments

10.13.6 SWOT Analysis

10.14 Danisco A/S

10.14.1 Company Overview

10.14.2 Financial Updates

10.14.3 Product/Business Segment Overview

10.14.4 Key Strategies

10.14.5 Key Developments

10.14.6 SWOT Analysis

10.15 Novus International Inc.

10.15.1 Company Overview

10.15.2 Financial Updates

10.15.3 Product/Business Segment Overview

10.15.4 Key Strategies

10.15.5 Key Developments

10.15.6 SWOT Analysis

List Tables Figures

List of Tables and Figures

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.